Compounds > telmisartan
Page last updated: 2024-08-24

telmisartan and Cognition Disorders

telmisartan has been researched along with Cognition Disorders in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (27.27)29.6817
2010's8 (72.73)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Braszko, JJ; Wincewicz, D1
Eriguchi, M; Fujisaki, K; Haruyama, N; Kitazono, T; Noguchi, H; Torisu, K; Tsuruya, K; Yamato, M1
Anderson, C; Böhm, M; Custodis, F; Diener, HC; Fagard, R; Laufs, U; Leong, D; Lonn, E; Mancia, G; O'Donnell, M; Redon, J; Schmieder, R; Schumacher, H; Sleight, P; Sliwa, K; Teo, K; Unger, T; Yusuf, S1
Anderson, C; Cukierman-Yaffe, T; Gao, P; Gerstein, HC; Teo, K; Yusuf, S1
Fujita, T; Horiuchi, M; Iwai, M; Iwanami, J; Li, JM; Min, LJ; Mogi, M; Sakata, A; Tsukuda, K1
Anderson, C; Cukierman-Yaffe, T; Gerstein, HC; Hilbrich, L; Jackson, SH; Sleight, P; Teo, K; Yusuf, S; Zhao, F1
Horiuchi, M; Iwai, M; Iwanami, J; Jing, F; Min, LJ; Mogi, M; Sakata, A; Tsukuda, K1
Fujita, Y; Ihara, M; Ito, H; Kihara, T; Maki, T; Nishio, K; Takahashi, J; Takahashi, R; Tomimoto, H; Washida, K; Wu, X; Yamada, M1
Anderson, C; Arima, H; Binbrek, A; Chazova, I; Commerford, P; Dans, A; Dyal, L; Gao, P; Holwerda, N; Paolasso, E; Pogue, J; Schumacher, H; Teo, K; Unger, T; Young, J; Yusuf, S1
Horiuchi, M; Iwanami, J; Jing, F; Min, LJ; Mogi, M; Ohshima, K; Shudou, M; Tsukuda, K1
Hirooka, Y; Kishi, T; Sunagawa, K1

Trials

2 trial(s) available for telmisartan and Cognition Disorders

ArticleYear
Dysglycemia and Cognitive Dysfunction and Ill Health in People With High CV Risk: Results From the ONTARGET/TRANSCEND Studies.
    The Journal of clinical endocrinology and metabolism, 2015, Volume: 100, Issue:7

    Topics: Aged; Aged, 80 and over; Aging; Benzimidazoles; Benzoates; Cardiovascular Diseases; Chronic Disease; Cognition Disorders; Dementia; Disabled Persons; Female; Glucose Metabolism Disorders; Humans; Male; Middle Aged; Ramipril; Risk Factors; Telmisartan

2015
Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies.
    The Lancet. Neurology, 2011, Volume: 10, Issue:1

    Topics: Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Cognition Disorders; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Mental Status Schedule; Neuropsychological Tests; Odds Ratio; Ramipril; Renin-Angiotensin System; Telmisartan; Treatment Outcome

2011

Other Studies

9 other study(ies) available for telmisartan and Cognition Disorders

ArticleYear
Telmisartan attenuates cognitive impairment caused by chronic stress in rats.
    Pharmacological reports : PR, 2014, Volume: 66, Issue:3

    Topics: Angiotensin II; Animals; Anxiety; Benzimidazoles; Benzoates; Cognition Disorders; Male; Maze Learning; Memory; Mental Recall; Motor Activity; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Stress, Psychological; Telmisartan

2014
Improvement in spatial memory dysfunction by telmisartan through reduction of brain angiotensin II and oxidative stress in experimental uremic mice.
    Life sciences, 2014, Sep-15, Volume: 113, Issue:1-2

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Brain; Cognition Disorders; DNA Damage; Lipid Peroxidation; Male; Maze Learning; Memory; Mice; Nephrectomy; Oxidative Stress; Reproducibility of Results; Spatial Behavior; Telmisartan; Uremia

2014
Systolic blood pressure variation and mean heart rate is associated with cognitive dysfunction in patients with high cardiovascular risk.
    Hypertension (Dallas, Tex. : 1979), 2015, Volume: 65, Issue:3

    Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular Diseases; Cognition Disorders; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Rate; Humans; Hypertension; Incidence; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Ramipril; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Telmisartan

2015
Telmisartan prevented cognitive decline partly due to PPAR-gamma activation.
    Biochemical and biophysical research communications, 2008, Oct-24, Volume: 375, Issue:3

    Topics: Amyloid beta-Peptides; Angiotensin II Type 1 Receptor Blockers; Anilides; Animals; Benzimidazoles; Benzoates; Brain; Cognition Disorders; Losartan; Male; Mice; Mice, Inbred Strains; PPAR gamma; Telmisartan

2008
Glucose intolerance and diabetes as risk factors for cognitive impairment in people at high cardiovascular risk: results from the ONTARGET/TRANSCEND research programme.
    Diabetes research and clinical practice, 2009, Volume: 83, Issue:3

    Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Glucose; Cardiovascular Diseases; Cognition; Cognition Disorders; Cross-Sectional Studies; Depression; Diabetes Mellitus; Diabetic Angiopathies; Drug Therapy, Combination; Female; Glucose Intolerance; Humans; Male; Middle Aged; Ramipril; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Telmisartan

2009
Cognitive deficit in amyloid-beta-injected mice was improved by pretreatment with a low dose of telmisartan partly because of peroxisome proliferator-activated receptor-gamma activation.
    Hypertension (Dallas, Tex. : 1979), 2009, Volume: 54, Issue:4

    Topics: Administration, Oral; Alzheimer Disease; Amyloid beta-Peptides; Angiotensin II Type 1 Receptor Blockers; Anilides; Animals; Benzimidazoles; Benzoates; Cerebellum; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Injections, Intraventricular; Male; Maze Learning; Mice; Mice, Inbred Strains; Nitric Oxide Synthase Type II; PPAR gamma; Regional Blood Flow; Telmisartan; Tumor Necrosis Factor-alpha

2009
Nonhypotensive dose of telmisartan attenuates cognitive impairment partially due to peroxisome proliferator-activated receptor-gamma activation in mice with chronic cerebral hypoperfusion.
    Stroke, 2010, Volume: 41, Issue:8

    Topics: Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Anilides; Animals; Benzimidazoles; Benzoates; Carotid Artery, Common; Carotid Stenosis; Cerebral Cortex; Chemokine CCL2; Cognition; Cognition Disorders; Immunohistochemistry; Male; Memory, Short-Term; Mice; Mice, Inbred C57BL; Oligodendroglia; Oxidative Stress; PPAR gamma; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Spatial Behavior; Telmisartan; Tumor Necrosis Factor-alpha

2010
Peroxisome proliferator-activated receptor-γ activation with angiotensin II type 1 receptor blockade is pivotal for the prevention of blood-brain barrier impairment and cognitive decline in type 2 diabetic mice.
    Hypertension (Dallas, Tex. : 1979), 2012, Volume: 59, Issue:5

    Topics: Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Anilides; Animals; Benzimidazoles; Benzoates; Blood Glucose; Blood-Brain Barrier; Blotting, Western; Cognition Disorders; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Losartan; Male; Maze Learning; Mice; Mice, Inbred C57BL; PPAR gamma; Random Allocation; Sensitivity and Specificity; Telmisartan

2012
Telmisartan protects against cognitive decline via up-regulation of brain-derived neurotrophic factor/tropomyosin-related kinase B in hippocampus of hypertensive rats.
    Journal of cardiology, 2012, Volume: 60, Issue:6

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Brain-Derived Neurotrophic Factor; Cognition Disorders; Disease Models, Animal; Hippocampus; Hypertension; Male; PPAR gamma; Protein Kinases; Rats, Inbred SHR; Receptor, trkB; Telmisartan; Up-Regulation

2012